Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg

Phase 2

Recruiting

Conditions: Sarcoma
Myxofibrosarcoma
Undifferentiated Pleomorphic Sarcoma
Alveolar Soft Part Sarcoma

Interventions: Procedure: Isolated Limb Infusion
Drug: Pembrolizumab
Drug: infusion of melphalan and dactinomycin

First Posted Date: 2020-04-03

Last Posted Date: 2025-05-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 30

Registration Number: NCT04332874

Locations: 🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities), Commack, New York, United States

and more 4 locations

Blinatumomab and Tyrosine Kinase Inhibitor Therapy in People With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Phase 2

Active, not recruiting

Conditions: Acute Lymphoblastic Leukemia
Philadelphia Chromosome-Positive

Interventions: Biological: Blinatumomab
Drug: dasatinib
Drug: dexamethasone
Drug: methotrexate

First Posted Date: 2020-04-01

Last Posted Date: 2025-05-02

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 17

Registration Number: NCT04329325

Locations: 🇺🇸
Mount Sinai Hospital, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Study of CAR-T Therapy in Older Patients

Active, not recruiting

Conditions: High-grade B-cell Lymphoma
DLBCL NOS
Multiple Myeloma
Lymphoma
Refractory B-Cell Lymphoma
Lymphoma, B-Cell

Interventions: Behavioral: Activities of Daily Living/ADLs
Behavioral: Instrumental Activity of Daily Living
Behavioral: Timed Up and Go
Behavioral: Cognition
Behavioral: Geriatric Depression Scale
Behavioral: Social Support
Behavioral: Brief Test of Attention
Behavioral: Trail Making Test
Behavioral: Controlled Oral Word Association Test
Behavioral: Hopkins Verbal Learning Test-Revised
Other: Blood draw

First Posted Date: 2020-03-09

Last Posted Date: 2025-04-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 141

Registration Number: NCT04300998

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Study of the Body's Response to Exercise and a Plant-Based Diet in Overweight Postmenopausal Women With Breast Cancer

Phase 2

Active, not recruiting

Conditions: Breast Cancer
Primary Hormone Receptor Positive Breast Cancer

Interventions: Other: Exercise Treatment
Other: Physical activity
Other: Nutrition counseling
Other: Plant-Based Diet
Other: Replication Exercise Test

First Posted Date: 2020-03-06

Last Posted Date: 2025-04-02

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 43

Registration Number: NCT04298086

Locations: 🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States

and more 4 locations

Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

Recruiting

Conditions: Endometrioid Adenocarcinoma
Endometrial Cancer
Endometrial Cancer Stage I

Interventions: Other: Physical exam

First Posted Date: 2020-03-02

Last Posted Date: 2025-05-15

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 1400

Registration Number: NCT04291612

Locations: 🇺🇸
Mayo Clinic (Data Collection and Data Analysis), Rochester, Minnesota, United States
🇺🇸
University of Miami (Data Collection Only), Miami, Florida, United States
🇺🇸
Miami Cancer Institute Baptist Health South Florida, Miami, Florida, United States

and more 16 locations

Dose Reduction of Postoperative Radiation for Soft Tissue Sarcoma of the Arms and Legs

Phase 2

Recruiting

Conditions: Soft Tissue Sarcoma

Interventions: Radiation: Intensity-modulated radiation therapy (IMRT)

First Posted Date: 2020-02-28

Last Posted Date: 2025-03-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 60

Registration Number: NCT04288375

Locations: 🇺🇸
Memorial Sloan Kettering Nassau (All protocol activities), Uniondale, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester (All protocol activities), Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (All protocol activities), Basking Ridge, New Jersey, United States

and more 4 locations

Observing People With Desmoid-Type Fibromatosis

Recruiting

Conditions: Desmoid Fibromatosis

Interventions: Diagnostic Test: Cross-sectional imaging

First Posted Date: 2020-02-24

Last Posted Date: 2025-05-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 100

Registration Number: NCT04281381

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

AG-120 in People With IDH1 Mutant Chondrosarcoma

Phase 2

Active, not recruiting

Conditions: Chondrosarcoma, Grade 3
IDH1 Gene Mutation
Chondrosarcoma
Chondrosarcoma, Grade 2

Interventions: Drug: AG-120

First Posted Date: 2020-02-20

Last Posted Date: 2025-05-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 6

Registration Number: NCT04278781

Locations: 🇺🇸
Johns Hopkins Hospital (Data Collection Only), Baltimore, Maryland, United States
🇺🇸
Columbia University (Specimen Analysis Only), New York, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 2 locations

Game-Based Physical Activity in Childhood Cancer Survivors

Not Applicable

Active, not recruiting

Conditions: Survivors of Childhood Cancer

Interventions: Other: Fitbit Inspire HR
Other: Questionaires

First Posted Date: 2020-02-12

Last Posted Date: 2025-03-07

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 48

Registration Number: NCT04266080

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer

Phase 2

Active, not recruiting

Conditions: Metastatic Prostate Cancer

Interventions: Drug: Atezolizumab
Drug: Abiraterone
Drug: Prednisone
Drug: GnRH analog
Radiation: Stereotactic Body Radiotherapy (SBRT)
Drug: Enzalutamide
Other: Follow up

First Posted Date: 2020-02-10

Last Posted Date: 2025-04-27

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 28

Registration Number: NCT04262154

Locations: 🇺🇸
Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Commack (Limited Protocol Activities), Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States

and more 5 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy